Investors in Apogee Enterprises, Inc. APOG need to pay close attention to the stock based on moves in the options market ...

NORTH CHICAGO, Ill. and SAN FRANCISCO and BOSTON, June 22, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Apogee Therapeutics (NASDAQ: APGE) ("Apogee") today announced they have entered into a ...

Apogee Enterprises, Inc. (Nasdaq: APOG) announced today that Christopher W. Ede has been appointed President of the Company's Architectural Glass segment. Prior to his appointment, Ede served as Vice ...

Detailed price information for Apogee Entrpr Inc (APOG-Q) from The Globe and Mail including charting and trades.

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Hannah Morrill Hannah Morrill is an editor covering gifts and beauty. After ...

AbbVie Inc. (NYSE:ABBV) is a research-based pharmaceutical company that develops and sells products to treat chronic diseases ...

There are a few likely reasons for the stocks rallying this week, according to RBC Capital Markets analyst Trung Huynh. These are three of the most solidly positioned drugmakers - all of which largely ...

Q1 fiscal 2027. Management View "Our team delivered revenue of $343 million and adjusted diluted EPS of $0.57 in the quarter, dem ...

Shares of Apogee Enterprises jumped after the company more than doubled its operating income despite a small decline in sales and swung to a quarterly profit. The stock was up 12% at $47.60 in ...

Architectural products company Apogee (NASDAQ:APOG) reported in Q2 CY2026, but sales fell by 1.1% year on year to $342.7 ...

Apogee Enterprises Inc. (APOG) on Friday reported fiscal first-quarter net income of $11.5 million, after reporting a loss in the same period a ...

Definium's Phase 3 LSD trial for depression beats with an 8.1-pt MADRS improvement, sending shares up 30%+ premarket. AbbVie ...